George R Simon MD
Executive Medical Director and Dept. Chair Moffitt-AdventHealth Joint Clinical Research Unit Professor of Medicine and Oncology H Lee Moffitt Cancer Center & USF Morsani School of Medicine
Join to view full profile
380 Celebration PlFl 2Celebration, FL 34747
Phone+1 843-792-1414
Fax+1 407-303-4803
Dr. Simon is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 1992 - 1997
Saint Joseph HospitalResidency, Internal Medicine, 1993 - 1995
Christian Medical College LudhianaClass of 1986
Certifications & Licensure
FL State Medical License 2000 - 2028
OH State Medical License 2024 - 2026
OK State Medical License 2020 - 2021
TX State Medical License 2012 - 2021
SC State Medical License 2010 - 2013
PA State Medical License 2008 - 2010
CO State Medical License 1997 - 2009
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
Publications & Presentations
PubMed
- 3 citationsSocial determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer.Molly Scannell Bryan, Xiaohan Hu, Monika A Izano, Hina Mohammed, Marianna Wicks
JNCI Cancer Spectrum. 2025-03-03 - 16 citationsComplement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.Jeffrey M Clarke, George R Simon, Hirva Mamdani, Lin Gu, James E Herndon 2nd
Nature Communications. 2025-01-02 - 10 citationsReal-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non-Small Cell Lung Cancer.Chiharu Sako, Chong Duan, Kevin Maresca, Sean Kent, Taly Gilat Schmidt
JCO Clinical Cancer Informatics. 2024-12-01
Press Mentions
Some Immune Systems Defeat Cancer. Could That Become a Drug?January 22nd, 2026- Mesothelioma Treatment Program Expanding in Central FloridaSeptember 8th, 2021
- Onc.AI Raises $6M Financing Round Co-Led by Blue Venture Fund and AccompliceDecember 3rd, 2020
Professional Memberships
- Member
- Fellow
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
